XML 117 R40.htm IDEA: XBRL DOCUMENT v3.20.4
Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2020
Fair Value Disclosures [Abstract]  
Schedule of Carrying and Estimated Fair Value of Other Financial Instruments
The following table presents the carrying amounts and estimated fair values of our financial instruments by hierarchy level as of December 31, 2020 and 2019:
December 31, 2020
Hierarchy Level
(Fair Value)
Carrying
Amount
Level 1Level 2Level 3
Liabilities
Acquisition-related contingent consideration, including
current portion (1)(2)
$20,118 $— $— $20,118 
2023 Convertible Notes (3)
286,131 — 396,982 — 
Total$306,249 $— $396,982 $20,118 
December 31, 2019
Hierarchy Level
(Fair Value)
Carrying
Amount
Level 1Level 2Level 3
Liabilities   
Acquisition-related contingent consideration, including
current portion (1)
$14,826 $— $— $14,826 
2023 Convertible Notes (3)
275,609 — 398,016 — 
Total$290,435 $— $398,016 $14,826 
(1)The short-term portion is included in “Accounts payable, accrued expenses and other,” and the long-term portion is included in “Other liabilities” on the Consolidated Balance Sheets.  
(2)During the year ended December 31, 2020, we acquired a strategy consulting and investment banking business that was assigned to the Corporate Finance segment and recorded an acquisition-related contingent consideration liability.
(3)The carrying values include unamortized deferred debt issue costs and debt discount.
Schedule of Acquisition-Related Contingent Consideration
The change in our liability for acquisition-related contingent consideration for our Level 3 financial instruments is as follows:
Contingent Consideration
Balance at December 31, 2017$3,750 
Accretion expense (1)
479 
Payments(531)
Balance at December 31, 2018$3,698 
Additions (2)
9,746 
Accretion expense (1)
2,372 
Payments(1,000)
Foreign currency translation adjustment (3)
10 
Balance at December 31, 2019$14,826 
Additions (2)
3,460 
Accretion expense (1)
5,593 
Payments(4,692)
Foreign currency translation adjustment (3)
931 
Balance at December 31, 2020$20,118 
(1)Accretion expense is included in "Selling, general and administrative expenses" on the Consolidated Statements of Comprehensive Income.
(2)During the years ended December 31, 2020 and 2019, we acquired businesses that were assigned to the Corporate Finance segment.
(3)Foreign currency translation adjustments are included in "Other comprehensive income (loss), net of tax" on the Consolidated Statements of Comprehensive Income.